Yu-Fang Huang
Researcher at Department of Medical Sciences; Clinical Neurophysiology
- E-mail:
- yu-fang.huang@uu.se
- Visiting address:
- Rudbecklaboratoriet C11, Dag Hammarsköldsv 20
75237 UPPSALA - Postal address:
- Rudbecklaboratoriet C11, Dag Hammarsköldsv 20
75237 UPPSALA
Publications
Recent publications
-
Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
Part of eBioMedicine, 2026
- DOI for Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
- Download full text (pdf) of Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
-
On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
Part of Journal of Neuromuscular Diseases, p. 493-506, 2026
- DOI for On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
- Download full text (pdf) of On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
-
Circulating Biomarkers and Complement-Associated Skeletal Muscle Pathology in Myasthenia Gravis
2026
-
Part of European Journal of Neurology, 2025
- DOI for AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
- Download full text (pdf) of AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
-
Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
Part of Muscle and Nerve, p. 284-289, 2024
- DOI for Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
- Download full text (pdf) of Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
All publications
Articles in journal
-
Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
Part of eBioMedicine, 2026
- DOI for Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
- Download full text (pdf) of Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
-
Part of European Journal of Neurology, 2025
- DOI for AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
- Download full text (pdf) of AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
-
Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
Part of Muscle and Nerve, p. 284-289, 2024
- DOI for Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
- Download full text (pdf) of Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
-
Part of Muscle and Nerve, p. 851-861, 2024
- DOI for Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis
- Download full text (pdf) of Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis
-
Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients
Part of Journal of Neuroimmunology, 2024
- DOI for Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients
- Download full text (pdf) of Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients
-
Part of iScience, p. 110564, 2024
- DOI for Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
- Download full text (pdf) of Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
-
STEM Structural Investigation of RE-Au-Si 1/1 Approximants
Part of Israel Journal of Chemistry, 2024
-
Part of Cells, 2022
- DOI for Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
- Download full text (pdf) of Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
-
Part of Frontiers in Immunology, 2020
- DOI for Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
- Download full text (pdf) of Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
Articles, review/survey
-
On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
Part of Journal of Neuromuscular Diseases, p. 493-506, 2026
- DOI for On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
- Download full text (pdf) of On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales